Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 923093 STAMFORD, CT

Position in AUPH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$764,237
-$242,814 QoQ
Shares Held
51,568
-18.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
10 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Derivatives in AUPH

reported options exposure · as of Mar 31, 2026
CallValue
$351,234
CallShares
23,700
PutValue
$345,306
PutShares
23,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $351,234 23,700
2026-03-31 $764,237 51,568
2026-03-31 $345,306 23,300
2025-12-31 $371,635 23,300
2025-12-31 $1,007,051 63,138
2025-12-31 $378,015 23,700
2025-09-30 $728,902 65,964
2024-03-31 $74,919 14,954
2023-09-30 $105,151 13,533
2023-03-31 $1,161,233 105,952
2022-12-31 $180,744 41,839
2022-06-30 $626,808 62,369
2021-12-31 $712,995 31,176
2021-09-30 $354,080 16,000